Vernakalant Versus Flecainide: Atrial Contractility

NCT01646281 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Vernakalant
DRUG: Flecainide

Sponsor

Maastricht University Medical Center